USPTO Announces Final Fee Changes Effective October 2, 2020

04 August 2020 PharmaPatents Blog
Authors: Courtenay C. Brinckerhoff

In a Federal Register Notice dated August 3, 2020, the USPTO published a final rule on fee changes that take effect October 2, 2020. The final rule implements fee changes we first learned about in August of 2018, with some adjustments made in response to feedback from the Patent Public Advisory Committee (PPAC) and public comments. 

Four Types Of Fee Adjustments 

As summarized on the USPTO fee-setting page, the final rule implements four types of fee adjustments: 

  1. An approximate 5% across-the-board adjustment to patent fees, explained as an approximate 2% annual increase “to help the USPTO keep up with inflation in order to achieve strategic goals.”
  2. Greater adjustments to specific fees “to encourage the effective administration of the IP system and to permit cost recovery for certain services.”
  3. New fees for non-DOCX filings ($400, with implementation delayed until January 2022) and for pro hac vice admission ($250 biannually).
  4. Four discontinued fees—three relating to patent service fees and one related to an Office of Enrollment and Discipline USPTO-assisted recovery of ID or password reset fee.

Significant October 2020 Fee Increases

A review of the USPTO’s Table of Patent Fee Adjustments shows a number of fees increasing by more than 5%, including the following (with Large Entity rates listed):

  • Issue Fee: 20% increase to $1200
  • First (3.5 year) Maintenance Fee: 25% increase to $2000
  • Late Maintenance Fee Payment Surcharge: 213% increase to $500
  • Expedited Examination of Design Patent Application: 78% increase to $1600
  • Inter Partes Review Request Fee: 23% increase to $19,000 
  • Post Grant Review Request Fee: 25% increase to $20,000 

The ~5% increases to the utility patent filing, search and examination fees will add up to $100 more, for a total of $1820. The increases to the PCT application transmittal and search fees will add up to $120 more, for a total of $2440. 

Raising Fees In These Challenging Times

According to the USPTO, the effective date was pushed back from July 2020 to October 2020, in view of “the state of the U.S. economy,” and “consistent with the USPTO’s many other efforts to provide various types of [coronavirus] relief to stakeholders.” As explained in the Federal Register Notice, the fee changes are designed to “provide the USPTO sufficient financial resources to facilitate the effective administration of the U.S. IP system,” including its efforts to improve patent quality and timeliness, support the work of the PTAB, and improve the “quality, efficiency, and productivity of patent operations” and the USPTO's IT systems.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.

Related Services